Deep Learning and Machine Learning for Alzheimer’s Disease Biomarker Identification
محل انتشار: دومین کنگره بین المللی هوش مصنوعی در علوم پزشکی
سال انتشار: 1404
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 97
متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
AIMS02_678
تاریخ نمایه سازی: 29 تیر 1404
چکیده مقاله:
Background and Aims: Alzheimer's Disease (AD), the most prevalent cause of dementia globally, is characterized by progressive cognitive decline that gradually impairs independent daily functioning. Current approaches to classify AD stages incorporate medical history, neuropsychological testing, genetic factors, and neuroimaging, including Magnetic Resonance Imaging (MRI). The application of Machine Learning (ML) and Deep Learning (DL) to early Alzheimer's Disease diagnosis and automated stage classification has attracted substantial research interest in recent years. This growing attention stems from both advances in neuroimaging technology and genetic analysis, coupled with these algorithms' unique capability to identify hidden patterns in complex biomedical data that may elude conventional analytical methods. Therefore, this study aims to (۱) analyze hidden patterns in AD concerning gene expression through unsupervised learning and (۲) develop a deep learning framework for accurate, automated AD classification using neuroimaging data. Methods: We first applied an unsupervised clustering method to the GSE۵۲۸۱ AD microarray dataset (NCBI) to identify hidden patterns. Next, we trained a Convolutional Neural Network (CNN) on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset to classify AD stages, comparing its performance against traditional machine learning models. Results: The clustering validity indices (such as Rand Index and Silhouette Score) reveal distinct gene expression patterns that may be associated with AD pathology. Subsequent evaluation of our CNN model on the ADNI dataset demonstrates superior classification performance (accuracy=۰.۹۳%), significantly outperforming traditional machine learning approaches in AD stage differentiation Conclusion: This study demonstrates the effectiveness of unsupervised clustering and CNN-based approaches for identifying AD biomarkers, while also highlighting current methodological limitations and promising future directions for improving Alzheimer's Disease diagnosis. Keywords: Machine learning, Deep learning, Alzheimer's Disease
کلیدواژه ها:
نویسندگان
Zohre Moattar Husseini
Department of Industrial Engineering & Management Systems, Amirkabir University of Technology, Tehran, Iran
Abbas Ahmadi
Department of Industrial Engineering & Management Systems, Amirkabir University of Technology, Tehran, Iran
Nafiseh Mohebi
Neurology Department, Iran University of Medical Sciences, Tehran, Iran